Insiders GlycoMimetics, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 12:24:46 2024-06-27 EDT			5-day change	1st Jan Change
0.291 ^USD	-0.31%		+15.92%	-87.72%

06-04	Transcript : GlycoMimetics, Inc. - Special Call
06-04	GlycoMimetics Announces Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia	CI

Insider Sell: Glycomimetics	23-01-27	MT
Insider Buy: Glycomimetics	22-12-28	MT
Insider Buy: Glycomimetics	22-11-16	MT
GlycoMimetics Names Edwin Rock as Chief Medical Officer	22-09-06	MT
GlycoMimetics, Inc. Appoints Edwin Rock as Chief Medical Officer	22-09-06	CI
GlycoMimetics, Inc. Appoints Bruce Johnson as Senior Vice President and Chief Commercial Officer	22-02-23	CI
GlycoMimetics, Inc. Announces Board Changes	21-08-05	CI
GlycoMimetics Announces Chief Executive Officer Changes	21-08-04	CI
BioCryst Pharmaceuticals : Names Helen Thackray Chief R&D Officer	21-03-19	MT
GlycoMimetics, Inc. Announces Resignation of Helen Thackray as Senior Vice President and Chief Medical Officer	21-02-23	CI
GlycoMimetics, Inc. Announces Executive Changes	21-02-23	CI
GlycoMimetics, Inc. Appoints Myra Rosario Herrle as Vice President, Regulatory Affairs	20-07-31	CI
GlycoMimetics, Inc. Announces Board Changes	19-04-29	CI
GlycoMimetics, Inc. Announces Board Changes	19-03-05	CI
GlycoMimetics, Inc. Appoints Scott Jackson to its Board of Directors	18-11-28	CI
Glycomimetics, Inc. Appoints Patricia S. Andrews to its Board of Directors	17-06-12	CI
GlycoMimetics Announces Board Changes	17-03-13	CI
GlycoMimetics, Inc. Announces the Intention of Franklin H. Top to Resign as Directors Effective January 1, 2017	16-09-23	CI
GlycoMimetics, Inc. Appoints Daniel Junius to Board of Directors	16-03-21	CI
GlycoMimetics, Inc. Appoints Mark A. Goldberg to Board of Directors	14-07-10	CI

No results for this search